OncoMed Pharmaceuticals is a top competitor of Enumeral Biomedical. OncoMed Pharmaceuticals was founded in Redwood City, California} in 2004. OncoMed Pharmaceuticals competes in the Biotechnology industry. Compared to Enumeral Biomedical, OncoMed Pharmaceuticals generates $43.7M more revenue.
Sorrento is Enumeral Biomedical's #2 competitor. Sorrento is headquartered in San Diego, California, and was founded in 1989. Sorrento competes in the Biotechnology field. Sorrento generates 8,880% the revenue of Enumeral Biomedical.
Fate Therapeutics has been one of Enumeral Biomedical's top competitors. Fate Therapeutics is a Public company that was founded in 2007 in San Diego, California. Like Enumeral Biomedical, Fate Therapeutics also competes in the Biotechnology industry. Compared to Enumeral Biomedical, Fate Therapeutics has 540 more employees.